Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Genomic Vision S.A. buy melinda

Start price
€7.46
17.03.16 / 50%
Target price
€8.50
23.03.16
Performance (%)
14.75%
End price
€8.56
23.03.16
Summary
This prediction ended on 23.03.16 with a price of €8.56. The BUY prediction by melinda finished with a performance of 14.75%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Genomic Vision S.A. - - - -
iShares Core DAX® 2.831% 1.236% 14.788% 17.647%
iShares Nasdaq 100 2.918% 0.640% 40.290% 50.762%
iShares Nikkei 225® 2.007% -2.135% 19.861% 4.937%
iShares S&P 500 2.257% 0.451% 30.090% 43.940%

According to melinda what are the pros and cons of Genomic Vision S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Genomic Vision S.A. diskutieren
Prediction Buy
Perf. (%) 14.75%
Target price 8.500
Change
Ends at 23.03.16

technologie



Genomic Vision : obtient la certification qualité NF EN ISO 13485:2012



Prediction Buy
Perf. (%) 14.75%
Target price 8.500
Change
Ends at 23.03.16

(Zielkurs erreicht)

Stopped prediction by melinda for Genomic Vision S.A.

buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.52
29.09.21
€0.75
29.09.22
-20.66%
09.10.21

Could be worthwhile Investment >10% per year
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.54
13.02.20
-
04.11.21
-2.46%
29.09.21

Could be worthwhile Investment >10% per year
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€8.60
23.03.16
€20.00
26.09.16
-15.12%
26.09.16

Could be worthwhile Investment >10% per year